Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajan P Kulkarni

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Journal of Biomedical Discovery and Collaboration|July 17, 2007
Nano-Bio-Genesis: tracing the rise of nanotechnology and nanobiotechnology as 'big science'Rajan P Kulkarni
Expert Review of Molecular Diagnostics|August 31, 2019
Circulating biomarkers predictive of tumor response to cancer immunotherapyErnest Y Lee, Rajan P Kulkarni
Regenerative Medicine|October 3, 2007
Will regulation determine the science agenda? A look at hESCsRajan P Kulkarni, Finbarr Livesey, Laure Dodin
Cutis|August 24, 2018
Ecthyma gangrenosum due to Pseudomonas fluorescensRyan E O'Leary, Vanessa Holland, Rajan P Kulkarni
JAMA Dermatology|April 6, 2022
To Improve Melanoma Outcomes, Focus on Risk Stratification, Not OverdiagnosisRajan P Kulkarni, Wesley Y Yu, Sancy A Leachman
International Journal of Dermatology|July 3, 2009
Clinicopathologic challengeRajan P Kulkarni, John C Sacoolidge, Melvin W Chiu
Clinical and Experimental Dermatology|July 18, 2022
Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapiesRiyad N H Seervai, Avilasha Sinha, Rajan P Kulkarni
Plos One|July 18, 2015
Counting White Blood Cells from a Blood Smear Using Fourier Ptychographic MicroscopyJaebum Chung, Xiaoze Ou, Rajan P Kulkarni, et al.
Expert Review of Molecular Diagnostics|October 4, 2022
Circulating biomarkers of response to immunotherapy and immune-related adverse eventsZachary Garrison, Noah Hornick, Jeffrey Cheng, et al.
Optics Letters|December 17, 2008
Characterization of high-Q optical microcavities using confocal microscopyRajan P Kulkarni, Scott E Fraser, Andrea M Armani
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Journal of Biomedical Discovery and Collaboration|July 17, 2007
Nano-Bio-Genesis: tracing the rise of nanotechnology and nanobiotechnology as 'big science'Rajan P Kulkarni
Expert Review of Molecular Diagnostics|August 31, 2019
Circulating biomarkers predictive of tumor response to cancer immunotherapyErnest Y Lee, Rajan P Kulkarni
Regenerative Medicine|October 3, 2007
Will regulation determine the science agenda? A look at hESCsRajan P Kulkarni, Finbarr Livesey, Laure Dodin
Cutis|August 24, 2018
Ecthyma gangrenosum due to Pseudomonas fluorescensRyan E O'Leary, Vanessa Holland, Rajan P Kulkarni
JAMA Dermatology|April 6, 2022
To Improve Melanoma Outcomes, Focus on Risk Stratification, Not OverdiagnosisRajan P Kulkarni, Wesley Y Yu, Sancy A Leachman
International Journal of Dermatology|July 3, 2009
Clinicopathologic challengeRajan P Kulkarni, John C Sacoolidge, Melvin W Chiu
Clinical and Experimental Dermatology|July 18, 2022
Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapiesRiyad N H Seervai, Avilasha Sinha, Rajan P Kulkarni
Plos One|July 18, 2015
Counting White Blood Cells from a Blood Smear Using Fourier Ptychographic MicroscopyJaebum Chung, Xiaoze Ou, Rajan P Kulkarni, et al.
Expert Review of Molecular Diagnostics|October 4, 2022
Circulating biomarkers of response to immunotherapy and immune-related adverse eventsZachary Garrison, Noah Hornick, Jeffrey Cheng, et al.
Optics Letters|December 17, 2008
Characterization of high-Q optical microcavities using confocal microscopyRajan P Kulkarni, Scott E Fraser, Andrea M Armani
Pageof 7